News | September 05, 2024
Exyte acquires TTP Group to accelerate growth of biopharma and life sciences business
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
e brings over 27+ years of rich pharmaceutical experience
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
Subscribe To Our Newsletter & Stay Updated
